Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study.

Saved in:
Bibliographic Details
Title: Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study.
Authors: Wu JY; Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin YM; Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, Taiwan., Hsu WH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Liu T; Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan., Tsai YW; Division of Preventive Medicine, Chi Mei Medical Center, Tainan, Taiwan., Huang PY; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Chuang MH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Yu T; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lai CC; Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan.; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Nov 19; Vol. 16, pp. 1709009. Date of Electronic Publication: 2025 Nov 19 (Print Publication: 2025).
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2392
DOI:10.3389/fendo.2025.1709009